Related Experiment Video
Updated: Jul 11, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation
Stéphane Ederhy1, Emanuele Di Angelantonio, Ziad Mallat
1Cardiology Department, Saint-Antoine University and Medical School, Université Pierre et Marie Curie, and INSERM U689, Hôpital Lariboisière, Paris, France.
Abstract:
Circulating procoagulant microparticles (MPs) arising from cell activation or fragmentation during apoptosis retain procoagulant properties and are increased in severe thrombotic states. We investigated whether circulating procoagulant MP levels would be increased in nonvalvular atrial fibrillation (AF). Using a hospital case-control study design, circulating procoagulant MP levels were measured in 45 patients with permanent and/or persistent AF who were not receiving anticoagulant therapy and 90 age-matched control subjects (45 with cardiovascular risk factors and 45 without). Annexin V-positive MP levels (expressed as nanomoles per liter of phosphatidylserine equivalent) were higher in patients with AF (median 9.3, interquartile range 6.8 to 17.3 nmol/L) than in control subjects with cardiovascular risk factors (median 4.9, interquartile range 3.7 to 8.4 nmol/L) and control subjects without cardiovascular risk factors (median 3.2, interquantile range 2.3 to 4.6 nmol/L; p<0.001). Platelet-derived MPs (captured with antiglycoprotein Ib) and endothelial-derived MPs (captured with anti-CD31) were similar in patients with AF and control subjects with cardiovascular risk factors but were significantly higher than in control subjects without cardiovascular risk factors. On multiple regression analysis, the presence of AF was a strong predictor of annexin V-positive MP level (p<.001). In conclusion, circulating procoagulant MPs are increased in persistent and/or permanent AF and might reflect a hypercoagulable state that could contribute to atrial thrombosis and thromboembolism.
Insights
Circulating procoagulant microparticles (MPs) are elevated in atrial fibrillation (AF) patients, indicating a hypercoagulable state. This finding may link AF to increased risk of thrombosis and thromboembolism.
Area of Science:
- Hematology
- Cardiology
- Thrombosis Research
Background:
- Circulating procoagulant microparticles (MPs) are cell fragments with procoagulant properties.
- Elevated MP levels are observed in severe thrombotic conditions.
- Atrial fibrillation (AF) is associated with an increased risk of thromboembolism.
Purpose of the Study:
- To investigate whether circulating procoagulant MP levels are increased in patients with nonvalvular atrial fibrillation (AF).
- To explore the potential link between elevated MPs and a hypercoagulable state in AF.
Main Methods:
- A hospital-based case-control study.
- Measurement of circulating Annexin V-positive MPs in 45 AF patients (without anticoagulant therapy) and 90 age-matched controls.
- Subgroup analysis of platelet-derived and endothelial-derived MPs.
Main Results:
- Annexin V-positive MP levels were significantly higher in AF patients compared to both control groups (p<0.001).
- Platelet-derived and endothelial-derived MPs were higher in AF patients than in controls without cardiovascular risk factors.
- AF was identified as a strong predictor of elevated Annexin V-positive MP levels (p<.001).
Conclusions:
- Circulating procoagulant MPs are elevated in persistent and/or permanent AF.
- Increased MP levels in AF may signify a hypercoagulable state.
- This hypercoagulability could contribute to the pathogenesis of atrial thrombosis and thromboembolism in AF patients.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Clot Retraction and Fibrinolysis
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

